These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
920 related articles for article (PubMed ID: 19262491)
1. Effect of L-NAME-induced hypertension on melatonin receptors and melatonin levels in the pineal gland and the peripheral organs of rats. Benova M; Herichova I; Stebelova K; Paulis L; Krajcirovicova K; Simko F; Zeman M Hypertens Res; 2009 Apr; 32(4):242-7. PubMed ID: 19262491 [TBL] [Abstract][Full Text] [Related]
2. Hypertensive response to chronic NG-nitro-L-arginine methyl ester (L-NAME) treatment is similar in immature and adult Wistar rats. Zicha J; Pechánová O; Dobesová Z; Kunes J Clin Sci (Lond); 2003 Oct; 105(4):483-9. PubMed ID: 12816535 [TBL] [Abstract][Full Text] [Related]
3. Melatonin protects myocardium from ischemia-reperfusion injury in hypertensive rats: role of myeloperoxidase activity. Sahna E; Deniz E; Bay-Karabulut A; Burma O Clin Exp Hypertens; 2008 Oct; 30(7):673-81. PubMed ID: 18855270 [TBL] [Abstract][Full Text] [Related]
4. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition. Sainz J; Wangensteen R; Rodríguez Gómez I; Moreno JM; Chamorro V; Osuna A; Bueno P; Vargas F Am J Hypertens; 2005 Jun; 18(6):871-7. PubMed ID: 15925750 [TBL] [Abstract][Full Text] [Related]
5. Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney. Bernátová I; Pechánová O; Simko F Exp Physiol; 1999 Nov; 84(6):1095-105. PubMed ID: 10564706 [TBL] [Abstract][Full Text] [Related]
6. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone. Paulis L; Matuskova J; Adamcova M; Pelouch V; Simko J; Krajcirovicova K; Potacova A; Hulin I; Janega P; Pechanova O; Simko F Acta Physiol (Oxf); 2008 Sep; 194(1):45-55. PubMed ID: 18419778 [TBL] [Abstract][Full Text] [Related]
7. Chronic N-acetylcysteine administration prevents development of hypertension in N(omega)-nitro-L-arginine methyl ester-treated rats: the role of reactive oxygen species. Rauchová H; Pechánová O; Kunes J; Vokurková M; Dobesová Z; Zicha J Hypertens Res; 2005 May; 28(5):475-82. PubMed ID: 16156512 [TBL] [Abstract][Full Text] [Related]
8. Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor. Paulis L; Zicha J; Kunes J; Hojna S; Behuliak M; Celec P; Kojsova S; Pechanova O; Simko F Hypertens Res; 2008 Apr; 31(4):793-803. PubMed ID: 18633192 [TBL] [Abstract][Full Text] [Related]
10. Nitric oxide synthase inhibition in rats: melatonin reduces blood pressure and ischemia/reperfusion-induced infarct size. Deniz E; Sahna E; Aksulu HE Scand Cardiovasc J; 2006 Aug; 40(4):248-52. PubMed ID: 16914418 [TBL] [Abstract][Full Text] [Related]
11. Effects of bulbus Fritillaria water extract on blood pressure and renal functions in the L-NAME-induced hypertensive rats. Kang DG; Sohn EJ; Lee YM; Lee AS; Han JH; Kim TY; Lee HS J Ethnopharmacol; 2004 Mar; 91(1):51-6. PubMed ID: 15036467 [TBL] [Abstract][Full Text] [Related]
12. Melatonin attenuates renal ischemia-reperfusion injury in nitric oxide synthase inhibited rats. Deniz E; Colakoglu N; Sari A; Sonmez MF; Tugrul I; Oktar S; Ilhan S; Sahna E Acta Histochem; 2006; 108(4):303-9. PubMed ID: 16764913 [TBL] [Abstract][Full Text] [Related]
13. Contribution of cytochrome P450 metabolites of arachidonic acid to hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME. Benter IF; Francis I; Cojocel C; Juggi JS; Yousif MH; Canatan H Auton Autacoid Pharmacol; 2005 Oct; 25(4):143-54. PubMed ID: 16176445 [TBL] [Abstract][Full Text] [Related]
14. Diabetes induces changes in melatonin concentrations in peripheral tissues of rat. Stebelová K; Herichová I; Zeman M Neuro Endocrinol Lett; 2007 Apr; 28(2):159-65. PubMed ID: 17435669 [TBL] [Abstract][Full Text] [Related]
15. Anti-lipid deposition effect of HMG-CoA reductase inhibitor, pitavastatin, in a rat model of hypertension and hypercholesterolemia. Kumai T; Oonuma S; Matsumoto N; Takeba Y; Taniguchi R; Kamio K; Miyazu O; Koitabashi Y; Sekine S; Tadokoro M; Kobayashi S Life Sci; 2004 Mar; 74(17):2129-42. PubMed ID: 14969717 [TBL] [Abstract][Full Text] [Related]
16. Effects of the aqueous extract of the Chinese medicine Danggui-Shaoyao-San on rat pineal melatonin synthesis. Qu HG; Cheng SW; Tian RB; Li ZL; Lei WL; Wang HQ; Yao ZB; He HW Neuro Endocrinol Lett; 2008 Jun; 29(3):366-72. PubMed ID: 18580848 [TBL] [Abstract][Full Text] [Related]
17. Role of circadian rhythm and endogenous melatonin in pathogenesis of acute gastric bleeding erosions induced by stress. Brzozowski T; Zwirska-Korczala K; Konturek PC; Konturek SJ; Sliwowski Z; Pawlik M; Kwiecien S; Drozdowicz D; Mazurkiewicz-Janik M; Bielanski W; Pawlik WW J Physiol Pharmacol; 2007 Dec; 58 Suppl 6():53-64. PubMed ID: 18212400 [TBL] [Abstract][Full Text] [Related]
18. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME). Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021 [TBL] [Abstract][Full Text] [Related]
19. Hypertensive effects of oral administration of the aqueous extract of Solanum torvum fruits in L-NAME treated rats: evidence from in vivo and in vitro studies. Nguelefack TB; Mekhfi H; Dongmo AB; Dimo T; Watcho P; Zoheir J; Legssyer A; Kamanyi A; Ziyyat A J Ethnopharmacol; 2009 Jul; 124(3):592-9. PubMed ID: 19439171 [TBL] [Abstract][Full Text] [Related]
20. Chronic low-dose L-NAME treatment effect on cardiovascular system of borderline hypertensive rats: feedback regulation? Kopincova J; Puzserova A; Bernatova I Neuro Endocrinol Lett; 2008 Oct; 29(5):784-9. PubMed ID: 18987608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]